Developers believe that the technology will reduce the risk of inflammation, thrombosis and other negative processes for patients in need of transplants
The unique technology for the creation of artificial receptacles, whose properties are closest to physiological, has been developed by scientists from the Institute of Cytology and Genetics (ICaG), Siberian Branch (SB) of the RAS and Novosibirsk State University (NSU). Development will reduce the risk of inflammation, thrombosis and other negative processes of patients in need of transplantation, reported to the NSU press service.
“For development, we used lining blood vessels and the vascular cages, taken from the postoperative material of the human infarction. The resettlement of vascular prosthetic devices by these cells will increase the life of the transplant,” the press service is quoted by the student NSU Anna Smirnov, who works at the epigenetics Development Laboratory of ICaG SB RAS.
The Institute explained that the technology for the creation of artificial receptacles was based on the resettlement of membranes from Polycaprolactone infarction cells. Synthetic materials used in vascular surgery have a number of physical defects, and the use of the patient’s own courts is often not possible on medical grounds.
“Developer scientists suggest that the new technology will reduce the risk of inflammation, thrombosis, and immunopathological processes that lead to the circulatory flow of circulation,” referred to in the communication.
For now development of Siberian biologists was held test on mice. Experiments have shown that the new technology has a number of advantages over existing ones and can be used to develop substitutes for small diameter receptacles. Development is being carried out with the support of the Russian Foundation for fundamental studies.
Original: Сибирские ученые разработали уникальную технологию создания искусственных сосудов. ТАСС.